Veraxa Biotech AG (VRXA)

NASDAQ: VRXA · Real-Time Price · USD

1.640

-0.090 (-5.20%)

At close: Aug 26, 2026, 4:00 PM EDT

1.650

+0.010 (0.61%)

Pre-market: Aug 27, 2026, 6:48 AM EDT

Veraxa Biotech AG Financials Overview

Financials in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Operating Income	-28.92	-28.92	-16.66
Net Income	-28.13	-28.13	-16.54
Earnings Per Share	-2.00	-2.00	-1.21
EPS Growth	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Investments	5.36	5.36	11.35
Total Debt	0.86	0.86	-
Net Cash (Debt)	4.5	4.5	11.35
Net Cash Growth	-	-60.38%	-
Net Cash Per Share	0.32	0.32	0.83

Cash Flow & CapEx

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Operating Cash Flow	-7.72	-7.72	-7.27
Capital Expenditures	-0.12	-0.12	-0.23
Free Cash Flow	-7.84	-7.84	-7.5
Free Cash Flow Growth	-	-	-

Valuation

Selected indicators aren't available for this stock.